LTR Pharma (ASX:LTP) Interest Income: A$1.11 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:LTP LTR Pharma Ltd ASX:LTP
7 GF Score
Price A$0.46
View Full Analysis

What is LTR Pharma Interest Income?

LTR Pharma ASX:LTP -7.14% 7 Interest Income is A$1.11 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 7/100.

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. LTR Pharma's interest income for the six months ended in Dec. 2025 was A$0.51 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.11 Mil.

LTR Pharma Interest Income Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Interest Income Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Interest Income
0.00 0.00 0.00 0.00 0.60

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Income Get a 7-Day Free Trial 0.00 0.00 0.00 0.60 0.51
ASX:LTP
7GF Score
LTR Pharma Ltd ASX:LTP
Interest Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Income →
What does a Interest Income of A$1.11 Mil mean?
LTR Pharma (ASX:LTP) has a Interest Income of A$1.11 Mil as of Dec. 2025. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Interest Income too high?
LTR Pharma's current Interest Income is A$1.11 Mil. Overall, LTR Pharma has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Interest Income compare to VRTX and REGN?
LTR Pharma's Interest Income of A$1.11 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Income for a Biotechnology company?
A good Interest Income depends on the Biotechnology industry context. However, Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Income mean?
A high Interest Income can signal that a stock is expensive relative to its fundamentals. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on LTR Pharma and its competitors. LTR Pharma's current Interest Income is A$1.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Interest Income of A$1.11 Mil. The current Interest Income is A$1.11 Mil. LTR Pharma's overall GF Score™ is 7/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Income calculated?
Interest Income is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Interest Income is A$1.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
7GF Score

Get the complete analysis for ASX:LTP

Interest Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.46
Price